Evidence map›Paper›PMID 37294277›Full record

ArticleImmunoHorizons2023

After Bone Marrow Transplantation, the Cell-Intrinsic Th2 Pathway Promotes Recipient T Lymphocyte Survival and Regulates Graft-versus-Host Disease.

Jamie Truscott, Xiaoqun Guan, Hope Fury, Tyler Atagozli, Ahmed Metwali, Weiren Liu, Yue Li, Robert W Li, David E Elliott, Bruce R Blazar and 1 more

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jamie TruscottDepartment of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA.ORCID 0000-0001-7126-3842
Xiaoqun GuanDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.
Hope FuryDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.
Tyler AtagozliDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.ORCID 0009-0007-4401-9431
Ahmed MetwaliDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.
Weiren LiuDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.
Yue LiDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.ORCID 0000-0001-7190-5454
Robert W LiAnimal Parasitic Diseases Laboratory, United States Department of Agriculture, Agricultural Research Service, Beltsville, MD.ORCID 0000-0001-9220-7049
David E ElliottDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.ORCID 0000-0002-5359-7125
Bruce R BlazarDivision of Blood and Marrow Transplantation & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN.ORCID 0000-0002-9608-9841
M Nedim InceDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA.ORCID 0000-0003-3451-3421
University of Iowa · USAgricultural Research Service · USUniversity of Minnesota · US

Funding

Single Cell Analysis and ImmunogeneticsP01HL158505 · NHLBI · DANA-FARBER CANCER INST · PI Corey S Cutler · 2022 to 2026
$15.3M
Enhancing Treg Therapeutic Efficacy in GVHDR01HL118979 · NHLBI · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, HIPPEN, KELI L · 2014 to 2025
$6.7M
T-CELL TARGETING FOR GVHDR01HL056067 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BLAZAR, BRUCE R · 1995 to 2022
$5.4M
In Vivo Prevention of Murine GVHDR37AI034495 · NIAID · UNIVERSITY OF MINNESOTA · PI Bruce R Blazar · 2017 to 2026
$5.4M
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemiaR01HL147324 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Bruce R Blazar, HANS-PETER KIEM · 2020 to 2026
$4.1M
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory DiseaseR01HL155114 · NHLBI · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, NOELLE, RANDOLPH J. · 2021 to 2024
$2.7M
BLRD VA I01 BX002715BLRD VA I01 BX002906NHLBI NIH HHS P01 HL158505NHLBI NIH HHS R01 HL056067NHLBI NIH HHS R01 HL118979NHLBI NIH HHS R01 HL147324NHLBI NIH HHS R01 HL155114NIAID NIH HHS R37 AI034495
6 · The paper itself

Abstract

Recipient T cells can aggravate or regulate lethal and devastating graft-versus-host disease (GVHD) after bone marrow transplantation (BMT). In this context, we have shown before that intestinal immune conditioning with helminths is associated with survival of recipient T cells and Th2 pathway-dependent regulation of GVHD. We investigated the mechanism of survival of recipient T cells and their contribution to GVHD pathogenesis in this helminth infection and BMT model after myeloablative preparation with total body irradiation in mice. Our results indicate that the helminth-induced Th2 pathway directly promotes the survival of recipient T cells after total body irradiation. Th2 cells also directly stimulate recipient T cells to produce TGF-β, which is required to regulate donor T cell-mediated immune attack of GVHD and can thereby contribute to recipient T cell survival after BMT. Moreover, we show that recipient T cells, conditioned to produce Th2 cytokines and TGF-β after helminth infection, are fundamentally necessary for GVHD regulation. Taken together, reprogrammed or immune-conditioned recipient T cells after helminth infection are crucial elements of Th2- and TGF-β-dependent regulation of GVHD after BMT, and their survival is dependent on cell-intrinsic Th2 signaling.

Indexed as

Bone Marrow TransplantationGraft vs Host DiseaseAnimalsCytokinesMiceTh2 CellsTransforming Growth Factor betaCytokinesTransforming Growth Factor beta

Identifiers

PMID37294277
PMCPMC10580113
OpenAlexW4379966217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.